TY  - GEN
AU  - Yi,Yong Weon
AU  - Kang,Hyo Jin
AU  - Bae,Edward Jeong
AU  - Oh,Seunghoon
AU  - Seong,Yeon-Sun
AU  - Bae,Insoo
TI  - β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells
SN  - 2092-6413
PY  - 2015///0916
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - drug effects
KW  - Cyclin E
KW  - genetics
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Furans
KW  - pharmacology
KW  - Gene Knockdown Techniques
KW  - Humans
KW  - Mechanistic Target of Rapamycin Complex 2
KW  - Models, Biological
KW  - Multiprotein Complexes
KW  - antagonists & inhibitors
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - Proteolysis
KW  - Proto-Oncogene Proteins c-myc
KW  - Pyridines
KW  - Pyrimidines
KW  - TOR Serine-Threonine Kinases
KW  - Triple Negative Breast Neoplasms
KW  - beta-Transducin Repeat-Containing Proteins
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/emm.2014.127
ER  -